News

Investigators in Kaiser Permanente Southern California and Kaiser Permanente Northern California have kicked off a new research project to develop better screening for latent tuberculosis. The project, led by Sara Tartof, PhD, MPH, an infectious disease epidemiologist with the Southern California Department of Research & Evaluation, is funded by the National Institute of Allergy and ...

Deborah A. Cohen, MD, MPH, an international expert on the health benefit of parks, is the newest scientist at the Department of Research & Evaluation. She began working in the department’s Division of Behavioral Research in January. She previously worked as a senior physician policy researcher at the RAND Corporation. She has served on panels for ...

In early March 2020, as it became clear the novel coronavirus was closing in on Southern California, clinical trials leaders from the Department of Research & Evaluation began assessing options for an investigational treatment that could be studied through clinical trials. With no approved medications to fight COVID-19, the need for an investigational option to ...

Kaiser Permanente’s clinical trials program helps advance treatment for health conditions ranging from heart disease and cancer to infectious diseases, such as HIV and COVID-19. William Towner, MD, FACP, FIDSA, physician director for clinical trials at Kaiser Permanente Southern California, has seen firsthand how clinical trials can contribute to the development of more effective and safer ...

At Kaiser Permanente Southern California, physicians and researchers have been transforming stroke care, from simply treating the patients to also enrolling those not helped by the standard care into a clinical trials program, which expands the treatment options. “Our stroke program shows how Kaiser Permanente is invested in growing our clinical care through clinical trials,” said ...

Kaiser Permanente Southern California researchers set out to understand the importance of emergency department patients and physicians speaking the same language by looking at the health outcomes and quality of care for patients with chest pain. They hypothesized that patients speaking a different language than their physician may have worse outcomes. They were happy to find ...

Investigators from Kaiser Permanente Southern California, led by Jaejin An, PhD, are among 12 scientific teams selected by the American Heart Association to fast-track research on heart and brain health related to COVID-19. The team will study the risks associated with taking antihypertensive medications in patients with confirmed COVID-19 infection and high blood pressure. “In conversations with ...

The Kaiser Permanente Southern California Regional Research Committee and the Care Improvement Research Team recently initiated 4 new rapid-cycle research projects that will help answer questions regarding prognosis for patients with suspected or confirmed COVID-19